Korean generic makers win Plavix patent lawsuit

Published: 2008-01-23 07:00:00

Updated: 2008-01-23 07:00:00

Korea's 17 generic makers have won the right to market Plavix (clopidogrel bisulfate) as a local patent court ruled on January 18 that Sanofi-Aventis's original patent is already expired.

However, experts say that a patent war surrounding Plavix patent will become fiercer as Sanofi-Aventis Kor...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK